发明名称 Makrocikliniai hepatito C serino proteazės inhibitoriai
摘要 The present invention relates to novel macrocyclic compounds and methods of use thereof. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
申请公布号 LTC2340029(I2) 申请公布日期 2016.12.27
申请号 LTPA2015011C 申请日期 2015.03.04
申请人 Enanta Pharmaceuticals, Inc.;AbbVie Bahamas Ltd. 发明人
分类号 主分类号
代理机构 代理人
主权项
地址